Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-07-23
DOI
10.3389/fonc.2019.00661
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer
- (2018) Michael T. Schweizer et al. PLoS One
- The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations
- (2018) Alexandra B. Keenan et al. Cell Systems
- Review of Drug Repositioning Approaches and Resources
- (2018) Hanqing Xue et al. International Journal of Biological Sciences
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data
- (2017) Amar Koleti et al. NUCLEIC ACIDS RESEARCH
- Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets
- (2017) Bin Chen et al. Nature Communications
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
- (2017) et al. JAMA Oncology
- Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer
- (2016) Kristine M Wadosky et al. International Journal of Biological Sciences
- Can you teach old drugs new tricks?
- (2016) Nicola Nosengo NATURE
- Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy
- (2016) Christoph A. von Klot et al. Oncology Letters
- TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples
- (2015) Liye He et al. BIOINFORMATICS
- A survey of current trends in computational drug repositioning
- (2015) Jiao Li et al. BRIEFINGS IN BIOINFORMATICS
- A Phase II Study of GW786034 (Pazopanib) With or Without Bicalutamide in Patients With Castration-Resistant Prostate Cancer
- (2015) Srikala S. Sridhar et al. Clinical Genitourinary Cancer
- Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group
- (2015) Cindy Ke Zhou et al. INTERNATIONAL JOURNAL OF CANCER
- Spatial genomic heterogeneity within localized, multifocal prostate cancer
- (2015) Paul C Boutros et al. NATURE GENETICS
- Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
- (2015) Colin S Cooper et al. NATURE GENETICS
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway
- (2015) Chen-Hsun Ho et al. PROSTATE
- A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma
- (2014) B. Rini et al. ANNALS OF ONCOLOGY
- LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures
- (2014) Qiaonan Duan et al. NUCLEIC ACIDS RESEARCH
- Chemical, Target, and Bioactive Properties of Allosteric Modulation
- (2014) Gerard J. P. van Westen et al. PLoS Computational Biology
- A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy
- (2013) Przemyslaw W. Twardowski et al. ANTI-CANCER DRUGS
- An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules
- (2013) Amrita Basu et al. CELL
- Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer
- (2013) Takashi Kobayashi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways
- (2013) Jing Tang et al. PLoS Computational Biology
- Transcriptional data: a new gateway to drug repositioning?
- (2012) Francesco Iorio et al. DRUG DISCOVERY TODAY
- Re: Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-weighted Magnetic Resonance Imaging–guided Biopsies Versus a Systematic 10-core Transrectal Ultrasound Prostate Biopsy Cohort
- (2012) Jinyi Li et al. EUROPEAN UROLOGY
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- Comprehensive literature review and statistical considerations for microarray meta-analysis
- (2012) George C. Tseng et al. NUCLEIC ACIDS RESEARCH
- Is Toxicogenomics a More Reliable and Sensitive Biomarker than Conventional Indicators from Rats To Predict Drug-Induced Liver Injury in Humans?
- (2011) Min Zhang et al. CHEMICAL RESEARCH IN TOXICOLOGY
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- MetaQC: objective quality control and inclusion/exclusion criteria for genomic meta-analysis
- (2011) Dongwan D. Kang et al. NUCLEIC ACIDS RESEARCH
- ChEMBL: a large-scale bioactivity database for drug discovery
- (2011) A. Gaulton et al. NUCLEIC ACIDS RESEARCH
- Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
- (2011) M. Sirota et al. Science Translational Medicine
- A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer
- (2011) Young E. Whang et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Discovery of drug mode of action and drug repositioning from transcriptional responses
- (2010) F. Iorio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biomarker detection in the integration of multiple multi-class genomic studies
- (2009) Shuya Lu et al. BIOINFORMATICS
- Systematic Evaluation of Drug–Disease Relationships to Identify Leads for Novel Drug Uses
- (2009) A P Chiang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started